Interferon-α as first-line therapy for treatment of multicentric Castleman's disease

Bowne, 1999, The management of unicentric and multicentric Castleman’s disease: A report of 16 cases and a review of literature, Cancer, 85, 706, 10.1002/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO;2-7

Advani, 1999, Treatment of multicentric Castleman’s disease complicated by the development of non-Hodgkin’s lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support, Ann Oncol, 10, 1207, 10.1023/A:1008366721816

Nishimoto, 2000, Improvement in Castleman’s disease by humanized anti-inlerleukin-6 receptor antibody therapy, Blood, 95, 56, 10.1182/blood.V95.1.56

Rieu, 1999, Retinoic acid for treatment of multicentric Castleman’s disease, Lancet, 354, 1262, 10.1016/S0140-6736(99)03957-4

Pavlidis, 1992, Interferon-a an active agent in Castleman’s disease?, Ann Oncol, 3, 85, 10.1093/oxfordjournals.annonc.a058082

Tamayo, 1995, Long-term complete remission after interferon treatment in a case of multicentric Castleman’s disease, Am J Haematol, 49, 359, 10.1002/ajh.2830490422